Translate page

Save-the-date for the 21st Annual John Goldman Conference on CML: Biology and Therapy 

JGM 2019

Bordeaux - September 12-15, 2019

Chairs: J. Cortes, T.P. Hughes, D.S. Krause

Registration for the meeting is now open. To register click here.
To submit your abstract online click here.

If you submitted an abstract for this year’s meeting: please look at your abstract number. 
If it begins with “12”, contact Camille Dufour immediately so that she can confirm that it has been registered for the peer review.

And please take note of the extended deadline for Abstracts: June 22nd, 2019

A prestigious faculty will address topics of high transversal interest to the International CML scientific community. 

The program will include:

  • iCMLf Prize ceremonies and key lectures
    • Janet Rowley Prize  (Michael Deininger)
    • John Goldman Prize (François-Xavier Mahon)
    • iCMLf Prize (Carolina Pavlovsky)
  • Other special lectures
    • Brian Druker (Portland): Perspectives on the development of TKI and its impact on our current understanding of CML
    • Sten Eirik Jacobsen (Stockholm): Stem cell hierarchy
    • Jeff Miller (Minneapolis): NK Cells
    • James DeGregori (Aurora): Adaptive oncogenesis
  • John Goldman Conferene Special Symposium 2019 
    Mechanisms of resistance to target-specific agents
    • Michael Deininger (Salt Lake City): TKI resistance in CML: is it all about mutations?
    • Andrew Intlekofer (New York): Elucidating mechanisms of response and resistance to mutant IDH inhibitors
    • Neil Shah (San Francisco): Mechanisms of resistance to FLT3 inhibitors and how to overcome them
    • Guy Sauvageau (Montreal): Even venetoclax can fail! How does it happen?
    • Andrei Thomas-Tikhonenko (Philadelphina): How lymphoid malignancies escape CART cells
  • Pharmaco-economics
    • François-Xavier Mahon (Bordeaux): How TFR may impact on economics in the long term
    • Antoine Benard (Bordeaux): Budget impact analysis of discontinuing tyrosine kinase inhibitors in patients with CML achieving a complete molecular response by using probabilistic Markov approach
  • Meet the Expert Sessions
    • Tim Hughes (Adelaide): How I treat CML
    • Neil Shah (San Francisco) and Shinya Kimura (Saga): Treatment Free Remission
    • Michael Mauro (New York) and Jeff Lipton (Toronto): TKI cardiovascular toxicity
    • Sten Eirik Jacobsen (Stockholm): Hematopoietic stem cell heterogeneity
  •  Workshops for non-clinical scientists 2019
    • Metabolism / Mitochondrial function in HSC and LSC (Chairs: Vignir Helgason (Glasgow) / Ravi Bhatia (Birmingham)
    • Role of inflammation in CML/MPN's (Chairs: Tim Brümmendorf (Aachen) / Rebekka Schneider-Kramann (Rotterdam)
  • Tutored Poster Walks
    • Leaders: Bob Gale (London) / Gianantonio Rosti (Bologna)
  • iCMLf John Goldman Fun Run on Sunday morning

Presentation of data at this conference will not jeopardize acceptance of the same at the following ASH congress.

Contact: or